Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Ivan Russo

Showing results (1-10 of 215) with videos related to

Pageof 22
Sort By:
Journal of Clinical Pathology|March 15, 2015
How to define cumulative cancer length for selecting candidate for active surveillance?Giorgio Ivan Russo, Giuseppe Morgia
International Journal of Impotence Research|February 28, 2024
ManAgement of pRiapiSm and its impact on outcomes: an international register (MARS study) - the first international, multicenter, observational study regarding priapism in perspectiveMaria Giovanna Asmundo, Giorgio Ivan Russo
European Urology Focus|May 18, 2020
Reply to Cosimo De Nunzio, Giacomo Novara, Rocco Damiano, Riccardo Bartoletti, Andrea Tubaro, and Vincenzo Ficarra's Letter to the Editor re: Giorgio Ivan Russo, Carmen Scandura, Marina Di Mauro, et al. Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2020.01.002. New Evidence Changing Clinical Practice or Misunderstanding of Statistical Analyses? The Case of Serenoa repens and α-BlockersGiorgio Ivan Russo, Giovanni Cacciamani, Andrea Cocci
Urologia|May 8, 2014
[5ARI and PSA: evidences]Giuseppe Morgia, Daniele Urzì, Giorgio Ivan Russo
Translational Andrology and Urology|November 19, 2020
Comment on: Safety and efficacy of mirabegron: analysis of a large integrated clinical trial database of patients with overactive bladder receiving mirabegron, antimuscarinics, or placeboCarmen Scandura, Giuseppe Morgia, Giorgio Ivan Russo
Neurourology and Urodynamics|February 27, 2016
Editorial comment to The efficacy of acupuncture in managing patients with chronic prostatitis/chronic pelvic pain syndrome: A systemic review and meta-analysisGiorgio Ivan Russo, Sebastiano Cimino, Giuseppe Morgia
International Journal of Impotence Research|December 15, 2019
Use of 3D printing in andrological surgery: what are the new perspectivesGiorgio Ivan Russo, Marina Di Mauro, Sebastiano Cimino
International Journal of Impotence Research|August 30, 2020
Problems in defining sexual dysfunction in prostate cancer patientsMarina Di Mauro, Giuseppe Morgia, Giorgio Ivan Russo
Andrologia|July 11, 2021
Reply to 'Penile length and circumference dimensions: A large study in young Italian men'Marina Di Mauro, Giorgio Ivan Russo, Andrea Cocci
Frontiers in Urology|November 24, 2025
Validation of AI-based semen analysis by urologists in training: clinical impact after varicocelectomyGiorgio Ivan Russo, Antonio Salvaggio, Maria Giovanna Asmundo
Pageof 22

Showing results (1-10 of 215) with videos related to

Sort By:
Pageof 22
Journal of Clinical Pathology|March 15, 2015
How to define cumulative cancer length for selecting candidate for active surveillance?Giorgio Ivan Russo, Giuseppe Morgia
International Journal of Impotence Research|February 28, 2024
ManAgement of pRiapiSm and its impact on outcomes: an international register (MARS study) - the first international, multicenter, observational study regarding priapism in perspectiveMaria Giovanna Asmundo, Giorgio Ivan Russo
European Urology Focus|May 18, 2020
Reply to Cosimo De Nunzio, Giacomo Novara, Rocco Damiano, Riccardo Bartoletti, Andrea Tubaro, and Vincenzo Ficarra's Letter to the Editor re: Giorgio Ivan Russo, Carmen Scandura, Marina Di Mauro, et al. Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2020.01.002. New Evidence Changing Clinical Practice or Misunderstanding of Statistical Analyses? The Case of Serenoa repens and α-BlockersGiorgio Ivan Russo, Giovanni Cacciamani, Andrea Cocci
Urologia|May 8, 2014
[5ARI and PSA: evidences]Giuseppe Morgia, Daniele Urzì, Giorgio Ivan Russo
Translational Andrology and Urology|November 19, 2020
Comment on: Safety and efficacy of mirabegron: analysis of a large integrated clinical trial database of patients with overactive bladder receiving mirabegron, antimuscarinics, or placeboCarmen Scandura, Giuseppe Morgia, Giorgio Ivan Russo
Neurourology and Urodynamics|February 27, 2016
Editorial comment to The efficacy of acupuncture in managing patients with chronic prostatitis/chronic pelvic pain syndrome: A systemic review and meta-analysisGiorgio Ivan Russo, Sebastiano Cimino, Giuseppe Morgia
International Journal of Impotence Research|December 15, 2019
Use of 3D printing in andrological surgery: what are the new perspectivesGiorgio Ivan Russo, Marina Di Mauro, Sebastiano Cimino
International Journal of Impotence Research|August 30, 2020
Problems in defining sexual dysfunction in prostate cancer patientsMarina Di Mauro, Giuseppe Morgia, Giorgio Ivan Russo
Andrologia|July 11, 2021
Reply to 'Penile length and circumference dimensions: A large study in young Italian men'Marina Di Mauro, Giorgio Ivan Russo, Andrea Cocci
Frontiers in Urology|November 24, 2025
Validation of AI-based semen analysis by urologists in training: clinical impact after varicocelectomyGiorgio Ivan Russo, Antonio Salvaggio, Maria Giovanna Asmundo
Pageof 22